Literature DB >> 6690630

Optimization of bioavailability of topical steroids: penetration enhancers under occlusion.

B W Barry, D Southwell, R Woodford.   

Abstract

The occluded vasoconstrictor assay was used to assess the effect of penetration enhancers on the topical bioavailability of a representative steroid, betamethasone 17-benzoate, with dimethylisosorbide (DMI) as a reference solvent. In the initial test, only N-methyl-2-pyrrolidone (NMP) increased the steroid bioavailability; acetone, dimethylformamide (DMF), 2-pyrrolidone (2-P), and 1-ethyl-2-pyrrolidone (EP) were equal to DMI, while propylene glycol (PG) and N,N-diethyl-m-toluamide (DEET) were poorer. Reocclusion showed that NMP and acetone established superior stratum corneum reservoirs; DMF, 2-P, EP, and PG were as effective as DMI but DEET was less effective. It was concluded that occlusive hydration and lack of thermodynamic control may have obscured the enhancing abilities of the solvents, 2-P, NMP, EP, DMF, and DEET induced erythema in some volunteers, although this was usually short-lived.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6690630     DOI: 10.1111/1523-1747.ep12259101

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

1.  The bioavailability of dermatological and other topically administered drugs.

Authors:  R H Guy; A H Guy; H I Maibach; V P Shah
Journal:  Pharm Res       Date:  1986-10       Impact factor: 4.200

2.  Determination of vehicle effects on percutaneous absorption by laser Doppler velocimetry.

Authors:  R H Guy; E Tur; L M Schall; S Elamir; H I Maibach
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

3.  High exposures to organic solvents among graffiti removers.

Authors:  H Anundi; M L Lind; L Friis; N Itkes; S Langworth; C Edling
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

4.  Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement.

Authors:  A C Williams; B W Barry
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.